Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (36)
COVID-19 (13)
Type
Type
Guidance (2013)
NICE advice (319)
Quality standard (197)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (21)
Antimicrobial resistance guidance (2)
Cancer service guidelines (5)
Clinical guidelines (229)
COVID-19 rapid guidelines (8)
HealthTech guidance (765)
Highly specialised technologies guidance (30)
Medicines practice guidelines (5)
NICE guidelines (335)
Public health guidelines (56)
Safe staffing guidelines (2)
Social care guidelines (69)
Technology appraisal guidance (881)
Advice programme
Advice programme
Evidence summaries (67)
Medtech innovation briefings (250)
NICE reviews (2)
Apply filters
Showing 321 to 330 of 2529
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Botulinum toxin type A for the prevention of headaches in adults with chronic migraine
TA260
27 June 2012
27 June 2012
Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision
HTG171
23 July 2008
23 July 2008
Brain tumours (primary) and brain metastases in over 16s
NG99
11 July 2018
29 January 2021
Brain tumours (primary) and brain metastases in over 16s
QS203
7 December 2021
7 December 2021
Breast cancer
QS12
28 September 2011
16 June 2016
Breast reconstruction using lipomodelling after breast cancer treatment
HTG280
23 January 2012
23 January 2012
Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphoma
TA577
24 April 2019
24 April 2019
Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma
TA524
13 June 2018
13 June 2018
Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphoma
TA478
4 October 2017
4 October 2017
Brentuximab vedotin in combination for untreated stage 3 or 4 CD30-positive Hodgkin lymphoma
TA1059
7 May 2025
7 May 2025
Previous page
1
…
31
32
Current page
33
34
35
…
253
Page
33
of
253
Next page
Results per page
10
25
50
All
Back to top